ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L

Authors:

Abstract
Despite the high prevalence of ERG transcription factor translocations in prostate cancer, the mechanism of tumorigenicity remains poorly understood. Using lineage tracing, we find the tumor-initiating activity of ERG resides in a subpopulation of murine basal cells that coexpress luminal genes (BasalLum) and not in the larger population of ERG+ luminal cells. Upon ERG activation, BasalLum cells give rise to highly proliferative intermediate (IM) cells with stem-like features that coexpress basal, luminal, hillock and club marker genes, before transitioning to Krt8+ luminal cells. Transcriptomic analysis of ERG+ human prostate cancers confirms the presence of rare ERG+ BasalLum cells, as well as IM cells whose presence is associated with a worse prognosis. Single-cell analysis revealed a chromatin state in ERG+ IM cells enriched for STAT3 transcription factor binding sites and elevated expression of the KMT2A/MLL1 and DOT1L, all three of which are essential for ERG-driven tumorigenicity in vivo. In addition to providing translational opportunities, this work illustrates how single-cell approaches combined with lineage tracing can identify cancer vulnerabilities not evident from bulk analysis.
All Related Versions
Funding Information
  • U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA193837, CA092629, CA224079, CA155169, 1K99CA276888-01, CA274492, CA008748, DK128602-03, CA008748, CA008748, CA008748, CA008748, CA224079, CA257811, CA274492)
  • Howard Hughes Medical Institute
  • U.S. Department of War (W81XWH-19-1-0323, W81XWH-21-1-0431)
  • Prostate Cancer Foundation (20YOUN22)

This publication has 120 references indexed in Scilit: